Health & Biotech

Fliers, flameouts and fakers: what happened in biotechland in 2018

December 21, 2018December 21, 2018 | David Langsam

Health & Biotech

Invion says its ovarian cancer cell killer is now 15x more deadly

September 25, 2018September 25, 2018 | Daniel Paproth

Health & Biotech

Cancer fighter Invion offloads respiratory drugs into China spin-off

September 5, 2018September 5, 2018 | Rachel Williamson

Health & Biotech

Here’s a bunch of top ASX respiratory stocks that will leave you breathless

August 22, 2018August 22, 2018 | Daniel Paproth

Health & Biotech

Invion goes flying after Photosoft treatment shown to zap ovarian cancer cells

July 5, 2018July 6, 2018 | Emma Koehn

News

Lunchtime ASX small cap wrap: who are the hot dogs so far today

July 5, 2018July 5, 2018 | Emma Koehn

Director Trades

Director Trades: Who cashed out and who spent $800K on shares for the wife?

April 23, 2018February 10, 2019 | Rachel Williamson

News

Lunchtime small cap wrap: who’s in the fast lane and who’s stalling

April 18, 2018April 18, 2018 | Melissa Yeo

Health & Biotech

How Invion plans to use light therapy to treat ovarian cancer

April 16, 2018March 18, 2019 | Tim Boreham

News

ASX small cap wrap: which stocks looked the strongest last week

March 23, 2018November 15, 2018 | Rachel Williamson

News

Lunchtime small cap wrap: who’s soaring and who’s missed the mark

March 15, 2018March 15, 2018 | Melissa Yeo

Mining & Resources

Half-time small cap wrap: Congo cobalt leaves platinum metals in its wake

March 1, 2018February 9, 2019 | Melissa Yeo